Chen Ping, Jin Qing, Fu Qiang, You Peidong, Jiang Xi, Yuan Qin, Huang Huifang
Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fujian, P.R. China.
Oncol Res. 2016;24(4):215-23. doi: 10.3727/096504016X14634208143021.
This study aimed to investigate the role of the PI3K/Akt signaling pathway in multidrug resistance of acute myeloid leukemia (AML) cells induced by cocultured stromal cells. Human AML cell lines HL-60 and U937 were adhesion cocultured with human bone marrow stromal cell line HS-5 cells. Such coculturing induced HL-60 and U937 cells resistant to chemotherapeutic drugs including daunorubicin (DNR), homoharringtonine (HHT), and cytosine arabinoside (Ara-C). The coculturing-induced resistance of AML cells to DNR, HHT, and Ara-C can be partially reversed by inhibition of the PI3K/Akt signaling pathway. Clinically, AML patients with a low level of PTEN and a high level of CCND1 had high relapse rates within 1 year, and newly diagnosed AML patients with extramedullary infiltration had a low level of PTEN. This study confirms the involvement of the PI3K/Akt signaling pathway in multidrug resistance in AML cells induced by stroma and suggests that the expression of PTEN and CCND1 may be a prognostic indicator for AML.
本研究旨在探讨PI3K/Akt信号通路在共培养基质细胞诱导的急性髓系白血病(AML)细胞多药耐药中的作用。将人AML细胞系HL-60和U937与人骨髓基质细胞系HS-5细胞进行黏附共培养。这种共培养诱导HL-60和U937细胞对包括柔红霉素(DNR)、高三尖杉酯碱(HHT)和阿糖胞苷(Ara-C)在内的化疗药物产生耐药。通过抑制PI3K/Akt信号通路,可部分逆转共培养诱导的AML细胞对DNR、HHT和Ara-C的耐药。临床上,PTEN水平低且CCND1水平高的AML患者1年内复发率高,新诊断的伴有髓外浸润的AML患者PTEN水平低。本研究证实PI3K/Akt信号通路参与了基质诱导的AML细胞多药耐药,并提示PTEN和CCND1的表达可能是AML的一个预后指标。